Moody’s Analytics Launches New Model of the Global Economy and Collaborative Forecasting Platform
Moody’s Analytics, a leading financial intelligence firm, is pleased to announce the launch of its new Global Macroeconomic Model. The model forecasts more than 10,000 globally inter-linked economic and financial time series that collectively account for 95% of global economic activity. The model is delivered through the Scenario Studio web-based platform, a Moody’s Analytics innovation that enables real-time interactive collaboration on economic scenarios or forecasts among multiple concurrent users.
Financial institutions, governments, and corporate clients can use the Global Macroeconomic Model to determine the impact of domestic and foreign economic shocks. The model accounts for trade flows, financial market conditions, migration, commodity prices and foreign investment. It captures the complexity of the global economy, and demonstrates that the economic impacts of government policy changes and geopolitical events are much larger and reverberate more broadly across the globe and for longer than is commonly thought.
“The global economy continues to become more integrated through trade, migration and investment,” said Mark Zandi, Moody’s Analytics Chief Economist. “With the global business and credit cycle maturing, the Global Macroeconomic Model provides a critical tool for assessing the impact of changing economic and monetary policy and geopolitical events, and for developing scenarios of future economic conditions.”
The model and web-based platform allow users to create multiple scenarios simultaneously. Forecasts obtained through the model are fully documented and transparent, supported by rigorous governance processes that stand up to regulatory and audit scrutiny. Advanced technology in the Scenario Studio platform helps clients generate scenarios required for regulatory compliance and accounting standards such as CCAR, ICAAP, IFRS9, and CECL.
“The Global Macroeconomic Model balances economic theory and empirical analysis,” added Marisa DiNatale, Global Head of Forecasting at Moody’s Analytics. “As demands on economists and risk managers increase, their tools have to keep pace with the increasing complexity of global economics and regulatory requirements. We are pleased to bring to market a powerful tool to help clients meet that need.”
This is the same global model and platform used by the Moody’s Analytics economics forecasting team, which is recognized for its national and sub-national forecasting and scenario analyses. Our economists are using the model to produce a series of research papers that investigate the global consequences of some of today’s most pressing and difficult economic questions, such as the escalating trade tensions between the U.S. and its trading partners, the cross-border consequences of Brexit and the recent political instability in Italy, swings in energy prices, and the potential break-up of the North American Free Trade Agreement.
In a paper published today, “ In No Good Hands: The Venezuela Crisis and Consequences for South America ”, Moody’s Analytics Economists, including Marisa DiNatale, use the Global Macroeconomic Model to assess the economic consequences for Venezuela and the rest of South America if Venezuela’s President Maduro serves out his new presidential term or if he is removed from office.
Other topics that the research series will cover include:
- Risks to China’s economy and the consequences for Southeast Asia. View First Paper
- US and trade: globalization and its discontents. View First Paper
- Climate Change: preparing for the economic fallout
- (Dis)unity in Europe
- Consumers: the engine of global growth?
- The Productivity Puzzle
Visit the Moody’s Analytics “Global Economic View” microsite for our latest research on these global themes.
To learn more about the Moody’s Analytics Global Model methodology and research, join our upcoming webinar, where economists, including Mark Zandi, will describe the capabilities of the global model and forecast governance processes, and highlight scenarios based on recent Moody’s Analytics research.
About Moody’s Analytics
Moody’s Analytics provides financial intelligence and analytical tools supporting our clients’ growth, efficiency and risk management objectives. The combination of our unparalleled expertise in risk, expansive information resources, and innovative application of technology helps today’s business leaders confidently navigate an evolving marketplace. We are recognized for our industry-leading solutions, comprising research, data, software and professional services, assembled to deliver a seamless customer experience. Thousands of organizations worldwide have made us their trusted partner because of our uncompromising commitment to quality, client service, and integrity.
Moody's Analytics is a subsidiary of Moody's Corporation (NYSE: MCO). MCO reported revenue of $4.2 billion in 2017, employs approximately 11,900 people worldwide and maintains a presence in 41 countries. Further information about Moody’s Analytics is available at www.moodysanalytics.com.
Om Business Wire
(c) 2018 Business Wire, Inc., All rights reserved.
Business Wire, a Berkshire Hathaway company, is the global leader in multiplatform press release distribution.
Følg saker fra Business Wire
Registrer deg med din epostadresse under for å få de nyeste sakene fra Business Wire på epost fortløpende. Du kan melde deg av når som helst.
Siste saker fra Business Wire
US FDA Approves ONTRUZANT® (trastuzumab-dttb), Samsung Bioepis’ First Oncology Medicine in the United States20.1.2019 23:38 | Pressemelding
Samsung Bioepis Co., Ltd. today announced that the U.S. Food and Drug Administration (FDA) has approved ONTRUZANT® (trastuzumab-dttb), a biosimilar referencing HERCEPTIN® 1 (trastuzumab), across all eligible indications, namely adjuvant treatment of HER2-overexpressing breast cancer, metastatic breast cancer and metastatic gastric cancer or gastroesophageal junction adenocarcinoma in patients who have not received prior treatment for metastatic disease. Please see Boxed Warnings and Important Safety Information for ONTRUZANT® below. ONTRUZANT® is Samsung Bioepis’ first oncology biosimilar to receive FDA approval, and will be marketed and distributed in the United States (US) by Merck, which is known as MSD outside of the US and Canada. “For many cancer patients in the US, battling cancer has not only been a health issue, but a considerable financial burden brought on by cancer treatment. Biosimilars are intended to be lower cost, high-quality treatment options that have the potential t
More4Apps to Join the Cloud20.1.2019 22:53 | Pressemelding
More4Apps, the NZ-based software integration specialist known for its Excel based Oracle EBS integration tools, has confirmed it will be building product for Cloud ERP. “We're overwhelmed by the number of customers asking for our solutions to be migrated to the new ERP system, and that’s driven our strategic commitment to developing Cloud-based data entry tools,” said Bruce Doig, co-founder and Head of Innovation at More4Apps. “Already we have a large team working closely with a well known US fast food restaurant chain to deliver several loaders integrated with Oracle ERP Cloud.” As a Gold Partner with Oracle, More4Apps is well positioned to develop a range of integration tools for the new platform, with an intimate knowledge of the existing EBS and a close working relationship with a customer with whom they are collaborating to develop data loaders for the new SaaS platform. And whilst the capabilities of Cloud ERP are yet to be fully proven, More4Apps are confident there will be a pl
Warm welcome for ABB Formula E in Davos19.1.2019 09:00 | Pressemelding
Just a few days before the start of the World Economic Forum 2019, Davos is celebrating a world premiere: The latest ABB FIA Formula E racing car - dubbed Gen2 – was transported on a train from the iconic Swiss Rhaetian Railway to Europe’s highest city, where it will be an exciting eyecatcher during the coming week at the Davos Platz railway station. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20190119005003/en/ ABB FIA Formula E racing car in Davos (Photo: Business Wire) From this Saturday until next Sunday, January 27, the Gen2 will be on display in a special glass case. Interested passersby can learn about the ABB FIA Formula E racing series as well as about the activities of ABB in e-mobility via an information system. With over 8,500 fast charging stations installed in 70 countries around the world, ABB is the global market leader for charging infrastructures. To watch the video, click here ABB (ABBN: SIX Swiss Ex) is
PMI’s Mission Winnow Goes Full Throttle with Ducati Corse for 2019 MotoGP™18.1.2019 17:00 | Pressemelding
Philip Morris International Inc. (PMI) (NYSE: PM) is pleased to announce that its Mission Winnow initiative is expanding in 2019 to include the Ducati Corse racing team. Mission Winnow is a PMI-led campaign to raise global awareness of our passion and determination to constantly improve and evolve, as well as highlight the power of science, technology and innovation to build a better future. PMI has partnered with Ducati Corse since 2002 and has extended the relationship for another three years until the end of 2021. As of the start of this year’s MotoGP season, the team will be officially known as Mission Winnow Ducati. Mission Winnow was first launched in October 2018 with Scuderia Ferrari Mission Winnow, which – like Ducati Corse – has a passion for innovation and a relentless drive to improve in the team’s pursuit of victory. Ducati Corse is one of the most inspiring and resilient teams in MotoGP, with a 70-year history in racing. Ducati fans form a passionate community who appreci
IFF’s Frutarom Division Completes Acquisition of 60% of Thailand-based Mighty18.1.2019 12:50 | Pressemelding
Regulatory News: International Flavors & Fragrances Inc. (NYSE:IFF) (Euronext Paris:IFF) (TASE:IFF), announced that its Frutarom Division has completed the acquisition of 60% of the share capital of The Mighty CO. LTD. (“Mighty”), a leading savory solutions provider in Thailand, thus continuing its growth strategy in Southeast Asia. Amos Anatot, President of IFF's Frutarom Division, said, “The completion of this deal with Mighty underscores that the Frutarom division will continue on its growth strategy and pursue attractive companies that create new opportunities or build on current capabilities.” Mr. Anatot continued, “And in this case, we are helping to grow our capabilities in savory solutions – already an area of strength for legacy Frutarom, now IFF." Mighty, founded in 1989, develops, produces and markets reaction flavors, with particular expertise in savory solutions. The company’s portfolio includes flavors, seasoning blends, marinades, and specialty functional raw materials f
LTI Q3 FY19: Constant currency revenue growth up 6.1% QoQ and 20.6% YoY; Net Profit jumps 32.8% YoY18.1.2019 12:02 | Pressemelding
Larsen & Toubro Infotech (BSE code: 540005, NSE: LTI), a global technology consulting and digital solutions company, announced its Q3 FY19 results today. In US Dollars: Revenue at USD 346.9 million; growth of 5.6% QoQ and 18.2% YoY Constant Currency Revenue growth of 6.1% QoQ and 20.6% YoY In Indian Rupees: Revenue at Rs 24,729 million; growth of 6.1% QoQ and 31.3% YoY Net Income at Rs 3,755 million; growth of (6.2%) QoQ and 32.8% YoY “We are pleased to deliver another strong quarter with 5.6% QoQ growth in USD revenues. Our broad-based revenue growth, superior margin delivery and steady cash generation in Q3 is a testimony of our focused execution and client centricity. We are also thrilled to welcome Ruletronics to LTI family. Ruletronics enables businesses to transform and evolve digitally by providing innovative BPM and CRM solutions leveraging Pega Platform.” - Sanjay Jalona, Chief Executive Officer & Managing Director, LTI Recent Deal Wins Nets, the leading payments company in th